Sun Min Lim

836 total citations
8 papers, 497 citations indexed

About

Sun Min Lim is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Sun Min Lim has authored 8 papers receiving a total of 497 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 2 papers in Molecular Biology. Recurrent topics in Sun Min Lim's work include Lung Cancer Treatments and Mutations (4 papers), Immunotherapy and Immune Responses (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Sun Min Lim is often cited by papers focused on Lung Cancer Treatments and Mutations (4 papers), Immunotherapy and Immune Responses (2 papers) and Cancer Immunotherapy and Biomarkers (2 papers). Sun Min Lim collaborates with scholars based in South Korea. Sun Min Lim's co-authors include Sewha Kim, Hee Jung An, Hye Ryun Kim, Min Hee Hong, Yong Wha Moon, Seung Ah Lee, Gun Min Kim, Joohyuk Sohn, Kamal Pandey and Seung‐Ki Kim and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Cancer.

In The Last Decade

Sun Min Lim

6 papers receiving 493 citations

Peers

Sun Min Lim

ONCOL

PRM

MB

CR

IMMUN

Rebecca Watters United States

Manuel Ruíz Borrego Spain

Paris Vail United States

Trine Lindsted United States

Alberto Verlicchi Italy

Ding Cheng Gao United States

Jason P.W. Carey United States

Matthew R. Strickland United States

Tharu M. Fernando United States

Rebecca Watters United States

Sun Min Lim

217 ×0.6

ONCOL

211 ×0.7

PRM

232 ×1.5

MB

139 ×1.3

CR

80 ×1.2

IMMUN

Citations per year, relative to Sun Min Lim Sun Min Lim (= 1×) peers Rebecca Watters

Countries citing papers authored by Sun Min Lim

Since Specialization

Citations

This map shows the geographic impact of Sun Min Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sun Min Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sun Min Lim more than expected).

Fields of papers citing papers by Sun Min Lim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sun Min Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sun Min Lim. The network helps show where Sun Min Lim may publish in the future.

Co-authorship network of co-authors of Sun Min Lim

This figure shows the co-authorship network connecting the top 25 collaborators of Sun Min Lim. A scholar is included among the top collaborators of Sun Min Lim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sun Min Lim. Sun Min Lim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Park, Sehhoon, Hee Kyung Ahn, S.Y. Lee, et al.. (2025). Lazertinib for Patients with NSCLC Harboring Uncommon EGFR Mutations: A Phase II Multicenter Trial. Journal of Thoracic Oncology. 20(9). 1279–1288.

2.

Lee, Jii Bum, et al.. (2024). Real-World Outcomes with Lurbinectedin in Second Line and Beyond for Extensive Stage Small Cell Lung Cancer in Korea. PubMed. Volume 15. 149–159. 1 indexed citations

3.

Kim, Jin‐A, Min Hee Hong, Sun Min Lim, et al.. (2024). Neoadjuvant chemotherapy followed by definitive local treatment in locally advanced sinonasal squamous cell carcinoma. Frontiers in Oncology. 14. 1488066–1488066.

4.

Hwang, Sohyun, Ah‐Young Kwon, Ju‐Yeon Jeong, et al.. (2020). Immune gene signatures for predicting durable clinical benefit of anti-PD-1 immunotherapy in patients with non-small cell lung cancer. Scientific Reports. 10(1). 643–643. 125 indexed citations

5.

Lim, Sun Min, Min Hee Hong, & Hye Ryun Kim. (2020). Immunotherapy for Non-small Cell Lung Cancer: Current Landscape and Future Perspectives. Immune Network. 20(1). e10–e10. 89 indexed citations

6.

Lim, Seungtaek, et al.. (2019). Sonic Hedgehog Pathway as the Prognostic Marker in Patients with Extensive Stage Small Cell Lung Cancer. Yonsei Medical Journal. 60(10). 898–898. 20 indexed citations

7.

Pandey, Kamal, Hee Jung An, Seung‐Ki Kim, et al.. (2018). Molecular mechanisms of resistance to CDK4/6 inhibitors in breast cancer: A review. International Journal of Cancer. 145(5). 1179–1188. 251 indexed citations

8.

Park, Hyung Soon, Sun Min Lim, Sora Kim, et al.. (2016). Pilot Study of a Next-Generation Sequencing-Based Targeted Anticancer Therapy in Refractory Solid Tumors at a Korean Institution. PLoS ONE. 11(4). e0154133–e0154133. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact